Piyushkumar R. Kapopara

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models.

CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 01, 2020

Erratum to: 'Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice'.

Erratum to: 'Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice'.

Journal: Vascular cell

Published: November 11, 2016

Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA.

Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA.

Journal: Blood

Published: October 24, 2016

Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.

Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.

Journal: Blood

Published: February 14, 2016

Functional promoter polymorphisms direct the expression of cystathionine gamma-lyase gene in mouse models of essential hypertension.

Functional promoter polymorphisms direct the expression of cystathionine gamma-lyase gene in mouse models of essential hypertension.

Journal: Journal of molecular and cellular cardiology

Published: February 03, 2016

MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis.

MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis.

Journal: PloS one

Published: June 13, 2014

Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.

Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury.

Journal: Thrombosis and haemostasis

Published: February 26, 2014

Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.

Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: July 23, 2013

Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells.

Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: February 21, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026